This study, CREST-HD, will examine the safety and tolerability of 8 grams of creatine in
subjects affected by Huntington's disease (HD). Biochemistry and neuroimaging will be used to
examine the potential effects of creatine on HD.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
National Center for Complementary and Integrative Health (NCCIH)